Latest Resources

GMOs in South Africa 23 years on: failures, biodiversity loss and escalating hunger

Transition to agroecology urgently needed This paper aims to update the public on activities and increased concerns since South Africa first approved the cultivation of genetically modified (GM) crops before the turn of the century. We are now living through a global pandemic, pointing to the imbalanced relationship between humans and our life-supporting systems and […]

Report from SADC regional farmer speak out on farm input subsidy programmes

Rural Women’s Assembly (RWA) and African Centre for Biodiversity (ACB) jointly hosted a meeting of farmers and civil society organisations (CSOs) in August 2018 to share views and experiences on farm input subsidy programmes (FISPs) and public sector support for agroecology in the region. About 140 participants from Namibia, South Africa, Zimbabwe, Mozambique, Zambia, Malawi, […]

GM Industry Called to Account: ISAAA’s report mischievous and erroneous

The Africa Centre for Biosafety (ACB) has dismissed the findings of the biotechnology industry’s flagship annual report, published by the GM industry funded ‘NGO’, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), as mischievous and erroneous. According to the report, South Africa’s GM crop area increased by a record 26% or 600,000 hectares […]

Lesotho – GMO Legislation

Evidently influenced by the UNEP-GEF Biosafety Project, the Biosafety Bill has been drafted principally to implement the Biosafety Protocol verbatim, and in so doing, perpetuates some of the weaknesses and deficiencies of the Biosafety Protocol. For instance, the scope of the Biosafety Bill is predicated on the scope of the Biosafety Protocol where the risks […]

Mozambique – GMO Legislation

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]